Although, several epidemiological studies associated low circulating levels of adiponectin with an increased BC risk and more aggressive phenotype, in particular, in post-menopausal women (regardless of BMI), this relationship has been observed prevalently in ER/PR-negative BCs [106]. The gene discussed is ADIPOQ; the disease is breast cancer.